Genericart Metformin Hydrochloride 1000mg Tablet SR is a sustained-release oral antihyperglycemic agent indicated for the management of type 2 diabetes mellitus. The active ingredient, Metformin hydrochloride 1000mg, belongs to the biguanide class and primarily acts by decreasing hepatic glucose production, reducing intestinal glucose absorption, and improving insulin sensitivity by enhancing peripheral glucose uptake and utilization. This multifaceted mechanism aids in achieving better glycemic control, thereby reducing fasting and postprandial blood glucose levels. The sustained-release formulation allows for a gradual release of the medication, promoting improved gastrointestinal tolerability and once-daily dosing convenience, which may enhance patient compliance. Genericart Metformin Hydrochloride 1000mg Tablet SR is typically prescribed as part of a comprehensive diabetes management plan that includes diet, exercise, and possibly other antidiabetic agents. It is contraindicated in patients with renal impairment, metabolic acidosis, or hypersensitivity to metformin. Common adverse effects include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort, which often diminish with continued use. Regular monitoring of renal function and blood glucose levels is recommended during therapy to ensure safety and efficacy. This medication should be used under medical supervision with appropriate lifestyle modifications to optimize therapeutic outcomes.